AUG 7·SEC EDGARLow
Jones John Jude sold $1.2M of MRSH
Jones John Jude (Chief Marketing Officer) sold 6,500 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $191.96 ($1.25M total) on 2026-08-06.
StockNYSE · US · USDFinancial Services · INSURANCE BROKERS
$MRSH
MARSH & MCLENNAN COMPANIES, INC.
Price · $MRSHvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $MRSH in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $4.8M 4 txs
Beswick Paul1× · $141K
10b5-1 plan25%
Top stories · $MRSHMore →
JUL 29·SEC EDGAR
South Martin sold $1.3M of MRSH
South Martin (Chief Client Officer) sold 7,100 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $189.99 ($1.35M total) on 2026-07-28.
JUL 24·SEC EDGAR
Yates Lloyd M sold $2.1M of MRSH
Yates Lloyd M sold 12,000 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $175.65 ($2.11M total) on 2026-07-23.
MRSH sentiment & insider activity
Recent MRSH coverage spans earnings and insider activity.
In the last 30 days, MRSH insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($4.8M). The most active reporter was Beswick Paul, SVP, Chief Information Officer, with 1 filing. 25% of activity was filed under pre-arranged Rule 10b5-1 plans.
What's driving MRSH
This is an insider sale disclosure, not a company fundamental update. It may slightly affect sentiment, but it does not change operating outlook.
This is a routine Form 4 open-market sale by a C-suite insider, with limited direct signal for fundamentals.
A director open-market sale is disclosed, but it is not tied to new fundamentals or guidance in the filing.
Earnings beat plus continued revenue growth and capital returns likely supports near-term upside bias, but segment mix (Guy Carpenter down) tempers conviction.
Earnings-call highlights point to continued margin expansion and higher 2026 capital deployment, with insurance rate declines as a key offsetting macro input.
alphai scores every news story that mentions MRSH with an AI model for sentiment and relevance, and aggregates insider trades from MARSH & MCLENNAN COMPANIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $MRSH
Score
Jones John Jude sold $1.2M of MRSH
Jones John Jude (Chief Marketing Officer) sold 6,500 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $191.96 ($1.25M total) on 2026-08-06.
1 min readSouth Martin sold $1.3M of MRSH
South Martin (Chief Client Officer) sold 7,100 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $189.99 ($1.35M total) on 2026-07-28.
1 min readYates Lloyd M sold $2.1M of MRSH
Yates Lloyd M sold 12,000 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $175.65 ($2.11M total) on 2026-07-23.
1 min readMarsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH)
Marsh & McLennan (NYSE:MRSH) reported Q2 adjusted EPS of $2.96, above the $2.90 consensus, and revenue of $7.4 billion versus $7.28 billion expected. Revenue rose 6% year over year. Adjusted operating income increased 5% to $2.2 billion. The company repurchased 4.5 million shares for about $750 million and raised its quarterly dividend to $0.990.
3 min readMarsh & McLennan Companies Q2 Earnings Call Highlights
Marsh & McLennan (NYSE:MRSH) reported Q2 results and discussed market conditions on its earnings call. Consulting revenue rose 10% to $2.6B, with adjusted operating income up 11% to $533M. Mercer revenue was $1.6B. Marsh Global Insurance Market Index showed primary commercial rates down 6% in Q2. The company ended with $20.6B debt and $1.7B cash, and expects $5.5B capital deployment in 2026.
5 min read
Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations
Marsh (NYSE:MRSH) reported Q2 CY2026 results. Revenue rose 6.2% year on year to $7.40 billion, exceeding Wall Street’s estimate by 1.8%, and non-GAAP EPS was $2.96, 2.3% above consensus. Adjusted operating margin was 26.9%. Analysts expect revenue growth of 4.2% and full-year EPS to rise from $10.22 to $10.90.
5 min readMarsh quarterly profit rises on strength in risk management business By Reuters
Marsh (MRSH) reported Q2 profit of $1.27 billion, or $2.63/share, up from $1.21 billion, or $2.45/share a year earlier, citing strong demand for its risk management and consulting units. Revenue in risk and insurance services rose 4% to $4.82 billion, consulting revenue grew 10%, and underlying revenue growth was 5%, according to Reuters and Marsh.
4 min readMARSH & MCLENNAN COMPANIES, INC. (MRSH): Results of Operations and Financial Condition
MARSH & MCLENNAN COMPANIES, INC. (MRSH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmc2q2026ex991newsrelease.htm PRESS RELEASE JUNE 30, 2026 Document Marsh 212 345 5000 www.corporate.marsh.com News release Exhibit 99.1 Marsh reports second quarter 2026 results • Revenue Growth of 6%; Underlying Revenue Growth of 5% • GAAP Operating Income Increases 4%
4 min read
Marsh (MRSH) To Report Earnings Tomorrow: Here Is What To Expect
Marsh (NYSE: MRSH) will report earnings Tuesday before the bell. Last quarter, it posted revenue of $7.60B, up 7.6% YoY, and beat analysts on revenue and EPS. This quarter, analysts expect revenue growth of 4.3% YoY. Marsh’s shares are up 13.4% over the past month, with an average price target of $200.52 versus $181.60.
4 min readDoyle John Q sold $2.7M of MRSH
Doyle John Q (President and CEO) sold 16,656 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $161.71 ($2.69M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
2 min read